CIK 0001631574
- Large accelerated filer
Wave Life Sciences, Inc.
Sign in to watch- Ticker
- WVE
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- Phone
- +1 617-949-2900
- Business address
- 733 CONCORD AVENUE, CAMBRIDGE, MA, 02138
- Former names
- Wave Life Sciences Ltd., Wave Life Sciences LTD., WAVE Life Sciences Ltd., Wave Life Sciences Pte Ltd
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Open-market sale Francis Chris sold 24,496 shares at an average $37.27 ($913,054)
- 4 Open-market sale Francis Chris sold 48,992 shares at an average $46.75 ($2,290,376)
- 4 Open-market sale President and CEO sold 31,711 shares at $45.00 ($1,426,995)
- 4 Open-market sale President and CEO sold 18,289 shares at $45.00 ($823,005)
- 4 Open-market sale Francis Chris sold 21,639 shares at an average $55.40 ($1,198,760)
- 4 Open-market sale President and CEO sold 2,714 shares at an average $51.50 ($139,783)
- 4 Open-market sale Franchise Lead, Neurology sold 511 shares at $52.10 ($26,623)
- 4 Open-market sale Chief Financial Officer sold 316 shares at $51.85 ($16,385)
- 4 Open-market sale Vargeese Chandra sold 2,000 shares at $50.00 ($100,000)
- 4 Open-market sale Franchise Lead, Neurology sold 18,750 shares at $50.00 ($937,500)
- 5 Insider Annual Insider Trading Report
- 4 Open-market sale Vargeese Chandra sold 2,000 shares at $40.00 ($80,000)
- 4 Grant or award Francis Chris acquired 13,000 shares (grant or award)
- 4 Grant or award Chief Financial Officer acquired 13,000 shares (grant or award)
- 4 Grant or award Franchise Lead, Neurology acquired 17,500 shares (grant or award)
Page 11 of 14 · 274 filings